Middlefield Healthcare Dividend Series A (MID330)
16.73
+0.01
(+0.04%)
CAD |
Dec 27 2024
Returns Chart
Key Stats
| Net Expense Ratio | Total Assets Under Management | Dividend Yield | Turnover Ratio |
|---|---|---|---|
| -- | -- | -- | -- |
| 1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized Total Returns Since Inception (Daily) | Max Drawdown (Since Inception) |
| -- | -- | Upgrade | Upgrade |
Basic Info
| Investment Strategy | |
| General | |
| Security Type | |
| Broad Asset Class | |
| Broad Category | |
| Global Peer Group | |
| Peer Group | |
| Global Macro | |
| US Macro | |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | |
| Fund Owner Firm Name | |
| Broad Asset Class Benchmark Index | |
Net Fund Flows Versus Peer Group
1 Month
% Rank:
--
--
Peer Group Low
--
Peer Group High
1 Year
% Rank:
--
--
Peer Group Low
--
Peer Group High
3 Months
% Rank:
--
--
Peer Group Low
--
Peer Group High
3 Years
% Rank:
--
--
Peer Group Low
--
Peer Group High
6 Months
% Rank:
--
--
Peer Group Low
--
Peer Group High
5 Years
% Rank:
--
--
Peer Group Low
--
Peer Group High
YTD
% Rank:
--
--
Peer Group Low
--
Peer Group High
10 Years
% Rank:
--
--
Peer Group Low
--
Peer Group High
Date Unavailable
Risk
Performance Versus Peer Group
Annual Total Returns Versus Peers
As of December 30, 2024.
Asset Allocation
| Type | % Net |
|---|---|
| Cash | -- |
| Stock | -- |
| Bond | -- |
| Convertible | -- |
| Preferred | -- |
| Other | -- |
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| Eli Lilly and Co ORD | 6.88% | 774.04 | -1.17% |
| Unitedhealth Group Inc ORD | 5.57% | 508.04 | -0.38% |
| Chartwell Retirement Residences | 5.32% | 15.03 | -0.99% |
| AbbVie Inc ORD | 5.10% | 176.10 | -1.07% |
| AstraZeneca PLC ORD | 5.04% | 130.19 | -1.37% |
| Boston Scientific Corp ORD | 4.53% | 89.67 | -1.09% |
| Merck & Co Inc ORD | 4.44% | 98.38 | -1.32% |
| Johnson & Johnson ORD | 4.25% | 143.33 | -1.19% |
| Stryker Corp ORD | 3.99% | 362.35 | -1.30% |
| Thermo Fisher Scientific Inc ORD | 3.95% | 518.63 | -1.41% |
Fees & Availability
| Fees | |
| Actual 12B-1 Fee | -- |
| Actual Management Fee | -- |
| Administration Fee | -- |
| Performance Fee | -- |
| Switching Fee | -- |
| Transaction Fee | -- |
| Maximum Front Load | -- |
| Maximum Deferred Load | -- |
| Maximum Redemption Fee | -- |
| General Availability | |
| Available for Insurance Product | No |
| Available for Retirement Plan | No |
| Available for RRSP | No |
| Purchase Details | |
| Open to New Investors | No |
| Open to Existing Investors | No |
| Minimum Initial Investment | -- |
| Minimum Subsequent Investment | -- |
Basic Info
| Investment Strategy | |
| General | |
| Security Type | |
| Broad Asset Class | |
| Broad Category | |
| Global Peer Group | |
| Peer Group | |
| Global Macro | |
| US Macro | |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | |
| Fund Owner Firm Name | |
| Broad Asset Class Benchmark Index | |
Fundamentals
| General | |
| Distribution Yield | -- |
| Dividend Yield TTM | -- |
| 30-Day SEC Yield | -- |
| 7-Day SEC Yield | -- |
| Stock | |
| Weighted Average PE Ratio | -- |
| Weighted Average Price to Sales Ratio | -- |
| Weighted Average Price to Book Ratio | -- |
| Weighted Median ROE | -- |
| Weighted Median ROA | -- |
| ROI (TTM) | -- |
| Return on Investment (TTM) | -- |
| Earning Yield | -- |
| LT Debt / Shareholders Equity | -- |
Growth Metrics
| EPS Growth (1Y) | -- |
| EPS Growth (3Y) | -- |
| EPS Growth (5Y) | -- |
| Sales Growth (1Y) | -- |
| Sales Growth (3Y) | -- |
| Sales Growth (5Y) | -- |
| Sales per Share Growth (1Y) | -- |
| Sales per Share Growth (3Y) | -- |
| Operating Cash Flow - Growth Ratge (3Y) | -- |
Growth Estimates
| Forecasted 5 Yr Earnings Growth | -- |
| Forecasted Book Value Growth | -- |
| Forecasted Cash Flow Growth | -- |
| Forecasted Earnings Growth | -- |
| Forecasted Revenue Growth | -- |
Fund Details
| Key Dates | |
| Inception Date | -- |
| Last Annual Report Date | -- |
| Last Prospectus Date | -- |
| Share Classes | |
| MID326 | Fee-based Advice |
| Attributes | |
| Index Fund | No |
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | No |
| Socially Responsible Fund | No |
Top Portfolio Holders
| Name | % Weight |
|---|---|
| Portfolio A | 5.00% |
| Portfolio B | 3.50% |
| Portfolio C | 2.25% |
Excel Add-In Codes
| Name: =YCI("M:MID330.TO", "name") |
| Broad Asset Class: =YCI("M:MID330.TO", "broad_asset_class") |
| Broad Category: =YCI("M:MID330.TO", "broad_category_group") |
| Prospectus Objective: =YCI("M:MID330.TO", "prospectus_objective") |
| To find the codes for any of our securities and financial metrics, see our Complete Excel Reference. |